You are here: Industry Insights > COVID-19

News List

One Dose of J.&J. Vaccine Is Ineffective Against Delta, Study Suggests firstwordpharma
July 21, 2021
According to results from a laboratory study posted online on Tuesday, Johnson & Johnson's COVID-19 vaccine is much less effective against the Delta and Lambda variants than against the original virus, The New York Times reported.
Japan Becomes First Country to Approve Regeneron Antibody Cocktail (casirivimab and imdevimab) for the Treatment of Mild to Moderate COVID-19 prnewswire
July 21, 2021
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Regeneron's casirivimab and imdevimab antibody cocktail to treat patients with mild to moderate COVID-19.
Global EdTech and Accessibility Company, Texthelp, Releases U.S. Data on Math and Writing Instruction During COVID-19 prnewswire
July 21, 2021
Texthelp is a global technology company that helps people understand and learn. Today they've released the results of their recent research study on math and writing instruction during the COVID-19 pandemic.
Debt.com poll: We'll Spend More Preparing for Natural Disasters Because of COVID-19 prnewswire
July 21, 2021
Americans will spend more preparing for natural disasters in 2021 than they did in 2020, and the reason is simple: COVID-19 showed just how scary life can be when you don't have enough supplies and planning.
Affinity Empowering and Eurofins Clinical to Provide Federally Funded COVID-19 Testing to Connecticut Students prnewswire
July 21, 2021
Affinity Empowering, Inc. today announced that they will provide COVID-19 testing to the summer students of the Horizons Program at Sacred Heart University (SHU) in Fairfield, Conn. as part of Operation Expanded Testing (OET).
ExoFlo™ From Direct Biologics Fulfills Urgent Medical Need in COVID-19 Treatment prnasia
July 21, 2021
As intensive care units across the country fill to capacity, hospital beds are in dangerously short supply, and deaths from COVID-19 continue to spike, doctors from medical centers coast to coast are reporting on the remarkable healing properties of ...
Direct Biologics Announces FDA Approval for Proceeding With Second ExoFlo IND for Post-Acute COVID-19 Syndrome and Chronic Post-COVID-19 Syndrome prnasia
July 21, 2021
Direct Biologics announced today that it has received FDA approval to initiate a Phase I/II trial under an Investigational New Drug (IND) protocol for the use of ExoFlo™ in the treatment of Post-Acute COVID-19 Syndrome.
Almost 70% of Doctors Say Covid-19 Vaccine Rates Would Be Higher If They Could Administer to Their Own Patients, New Survey Shows b3cnewswire
July 21, 2021
With variants on the rise and the continued need for vaccinations, a new global survey of physicians finds that many doctors believe that they may be the key to boosting vaccination rates as they are an important source of information, comfort.
Celltrion says its COVID-19 antibody shows ‘strong neutralising activity’ against Delta variant pharmatimes
July 21, 2021
Celltrion has announced that its COVID-19 antibody treatment regdanvimab has a ‘strong neutralising effect’ against the Delta variant first identified in India.
Within weeks of first COVID-19 outbreak, China's Qingdao Weida Biotechnology had switched all production capability over to PPE prnasia
July 20, 2021
On July 16, 2021, organized by the Information Office of the People's Government of Shandong Province, a delegation of journalists from foreign media organizations who were participating in the 2021 Qingdao Multinationals Summit (QMS) paid a visit to ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page